Lipophage 60 Capsule contains Orlistat 60 mg, an effective anti-obesity agent indicated for weight management in overweight and obese adults. Orlistat acts locally in the gastrointestinal tract by inhibiting pancreatic and gastric lipases, enzymes responsible for the hydrolysis of dietary triglycerides into absorbable free fatty acids and monoglycerides. By blocking these enzymes, Lipophage reduces the absorption of dietary fats by approximately 30%, promoting weight loss when used in conjunction with a reduced-calorie, low-fat diet. This medication is intended for adults with a body mass index (BMI) of 30 kg/m² or greater, or those with a BMI of 27 kg/m² or greater who have associated risk factors such as hypertension, diabetes, or dyslipidemia. Lipophage 60 Capsule should be taken orally with each main meal containing fat, preferably during or up to one hour after the meal. Common adverse effects include gastrointestinal symptoms such as oily spotting, flatulence with discharge, and fecal urgency, which are generally mild and related to dietary fat intake. Patients are advised to adhere to a balanced diet to minimize side effects and ensure optimal therapeutic outcomes. Regular monitoring of liver function and fat-soluble vitamin levels is recommended during prolonged use. Lipophage 60 Capsule is a valuable adjunct in comprehensive weight management programs.